AGPAT4 and neoplasm: In line with the role of Agpat4 in MC-38 tumors, Agpat4 deficiency markedly suppressed CT-26 tumor progression in the peritoneal (Fig. 2k) and subcutaneous xenograft models (Fig. 2l).